CRINONE 8 %
PROGESTERONE : 8 % · DIN 02241013 · EMD SERONO, A DIVISION OF EMD INC., CANADA
Health Canada status: MARKETED
What is CRINONE?
CRINONE 8 % contains PROGESTERONE : 8 %. It is listed in the Health Canada Drug Product Database under DIN 02241013, held by EMD SERONO, A DIVISION OF EMD INC., CANADA, supplied as GEL for VAGINAL administration. Health Canada currently lists it as marketed, status dated 12-Jun-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CRINONE used for?
CRINONE (Progesterone gel) 8% is indicated for: luteal phase support in induced cycles such as In Vitro Fertilization (IVF) cycles including in oocyte donation recipient.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02241013 |
|---|---|
| Brand name | CRINONE |
| Generic / active ingredient | PROGESTERONE : 8 % |
| Manufacturer | EMD SERONO, A DIVISION OF EMD INC., CANADA |
| Strength | 8 % |
| Dosage form | GEL |
| Route of administration | VAGINAL |
| Schedule | Prescription |
| ATC code | G03DA04 PROGESTERONE |
| AHFS class | 88:28.01* ; See footnote |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 12-Jun-2000 |
| Original market date | 2000-01-12 00:00:00 |
How is it stored and handled?
CRINONE gel should be stored at room temperature (15 - 25 ° C) and not exposed to extreme heat or cold.
How is it supplied?
Applicators are packaged in cartons of 6 and 18 per box.
Is PROGESTERONE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANIS HEALTH INC (Tier 3 Drug Shortages About & Resources), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code G03DA04 PROGESTERONE. 9 of 17 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACT PROGESTERONE INJECTION | 50 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED | DIN 02446820 |
| AURO-PROGESTERONE | 100 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02493578 |
| PMS-PROGESTERONE | 100 MG | CAPSULE | PHARMASCIENCE INC | MARKETED | DIN 02476576 |
| PROGESTERONE | 100 MG | CAPSULE | SANIS HEALTH INC | MARKETED | DIN 02516187 |
| PROGESTERONE INJECTION, USP | 50 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02531828 |
| PROMETRIUM | 100 MG | CAPSULE | ORGANON CANADA INC. | MARKETED | DIN 02166704 |
| REDDY-PROGESTERONE | 100 MG | CAPSULE | DR. REDDY'S LABORATORIES INC | MARKETED | DIN 02463113 |
| TEVA-PROGESTERONE | 100 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | DIN 02439913 |
| ENDOMETRIN | 100 MG | VAGINAL TABLET, EFFERVESCENT | FERRING INC | DORMANT | DIN 02334992 |
| EUGIA-PROGESTERONE | 100 MG | CAPSULE | EUGIA PHARMA INC. | APPROVED | DIN 02546493 |
Who else supplies PROGESTERONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PROGESTERONE appears in 127 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.